Kennedy Hodges, L.L.P. Legal Blog

The Food and Drug Administration released a list of 20 medications Friday that are currently under investigation for potential safety problems. The release of the list comes after Congress last year ordered the agency to produce a quarterly report of drugs being investigated by regulators. Consumer advocates have complained that the list, which states little more than the name of the drugs and their potential safety problems, will be of little use to patients. Ricardo Alonso-Zaldivar, Yahoo News 09/05/2008
Read Article

The following is the list:

Arginine Hydrochloride Injection (R-Gene 10)
Pediatric overdose due to labeling / packaging confusion

Desflurane (Suprane)
Cardiac arrest

Duloxetine (Cymbalta)
Urinary retention

Etravirine (Intelence)
Hemarthrosis

Fluorouracil Cream (Carac) and Ketoconazole Cream (Kuric)
Adverse events due to name confusion

Heparin
Anaphylactic-type reactions

Icodextrin (Extraneal)
Hypoglycemia

Insulin U-500 (Humulin R)
Dosing confusion

Ivermectin (Stromectol) and Warfarin
Drug interaction

Lapatinib (Tykerb)
Hepatotoxicity

Lenalidomide (Revlimid)
Stevens Johnson Syndrome

Natalizumab (Tysabri)
Skin melanomas

Nitroglycerin (Nitrostat)
Overdose due to labeling confusion

Octreotide Acetate Depot (Sandostatin LAR)
Ileus

Oxycodone Hydrochloride Controlled-Release (Oxycontin)
Drug misuse, abuse and overdose

Perflutren Lipid Microsphere (Definity)
Cardiopulmonary reactions

Phenytoin Injection (Dilantin)
Purple Glove Syndrome

Quetiapine (Seroquel)
Overdose due to sample pack labeling confusion

Telbivudine (Tyzeka)
Peripheral neuropathy

Tumor Necrosis Factor (TNF) Blockers
Cancers in children and young adults